11 analysts have expressed a variety of opinions on Elevance Health (NYSE:ELV) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Analysts have set 12-month price targets for Elevance Health, revealing an average target of $559.91, a high estimate of $622.00, and a low estimate of $478.00. Observing a downward trend, the current average is 7.03% lower than the prior average price target of $602.27.

Decoding Analyst Ratings: A Detailed Look

The standing of Elevance Health...